Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
uniQure N.V. - Ordinary Shares
(NQ:
QURE
)
14.77
-0.83 (-5.32%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about uniQure N.V. - Ordinary Shares
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
uniQure Announces 2025 Financial Results and Provides Recent Company Updates
March 02, 2026
From
uniQure Inc.
Via
GlobeNewswire
uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease
March 02, 2026
From
uniQure Inc.
Via
GlobeNewswire
Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline
February 28, 2026
Did you buy QURE ordinary shares between September 24, 2025, and October 31, 2025?
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline
February 28, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
uniQure N.V. (QURE) Investors: April 13, 2026, Deadline in Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP
February 27, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
uniQure N.V. (QURE) Investors: April 13, 2026, Deadline in Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP
February 27, 2026
Did you buy QURE ordinary shares between September 24, 2025, and October 31, 2025?
Via
TheNewswire.com
Topics
Fraud
Lawsuit
QURE Or RGNX: Which Gene Therapy Was FDA Chief Really Warning About In Rare Disease Remarks?
↗
February 27, 2026
Analysts are divided on the target, with RBC Capital and Stifel saying the comments appeared to reference uniQure, while Leerink argued they more closely align with Regenxbio’s RGX-121.
Via
Stocktwits
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
↗
February 26, 2026
Via
Chartmill
FDA Commissioner Refers To Rare Disease Drug With Associated Morbidity: Analysts Are Divided If Makary Meant Regenxbio Or Uniqure’s Experimental Therapy
↗
February 26, 2026
Following the comments, shares of both Regenxbio and uniQure traded in the red.
Via
Stocktwits
Thursday's session: top gainers and losers
↗
February 26, 2026
Via
Chartmill
Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline
February 26, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline
February 26, 2026
Did you buy QURE ordinary shares between September 24, 2025, and October 31, 2025?
Via
TheNewswire.com
Topics
Fraud
Lawsuit
There are notable gap-ups and gap-downs in today's session.
↗
February 26, 2026
Via
Chartmill
UNIQURE N.V. (QURE) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds uniQure N.V. Investors of Upcoming Deadline
February 26, 2026
From
Bernstein Liebhard LLP
Via
GlobeNewswire
uniQure Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against uniQure N.V. - QURE
February 25, 2026
From
SkyMedia, LLC
Via
GlobeNewswire
UNIQURE CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Encourages uniQure N.V. Stockholders with Large Losses to Contact the Firm
February 25, 2026
From
Bragar Eagel & Squire
Via
GlobeNewswire
QURE INVESTOR REMINDER: uniQure N.V. Investors Have Until April 13, 2026 To Seek Lead Plaintiff Role
February 25, 2026
From
Kirby McInerney LLP
Via
Business Wire
QURE CLASS ACTION REMINDER: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026
February 25, 2026
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
February 24, 2026
From
Kahn Swick & Foti, LLC
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in uniQure N.V. of Class Action Lawsuit and Upcoming Deadlines – QURE
February 24, 2026
From
Pomerantz LLP
Via
GlobeNewswire
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm
February 24, 2026
From
Schall Law
Via
GlobeNewswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against uniQure N.V.
February 24, 2026
From
Bernstein Liebhard LLP
Via
GlobeNewswire
uniQure N.V. (QURE) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit - Contact Kessler Topaz Meltzer & Check, LLP
February 23, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
uniQure N.V. (QURE) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit - Contact Kessler Topaz Meltzer & Check, LLP
February 23, 2026
RADNOR, PA - February 23, 2026 (NEWMEDIAWIRE) - Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against uniQure N.V. (NASDAQ: QURE)...
Via
TheNewswire.com
Topics
Fraud
Lawsuit
uniQure to Announce 2025 Financial Results
February 23, 2026
~ uniQure to host earnings call on Monday, March 2, 2026 at 8:00 a.m. ET ~
From
uniQure Inc.
Via
GlobeNewswire
Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline
February 22, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline
February 22, 2026
Did you buy QURE ordinary shares between September 24, 2025, and October 31, 2025?
Via
TheNewswire.com
Topics
Fraud
Lawsuit
uniQure N.V. (QURE) Investors: April 13, 2026, Deadline in Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP
February 21, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
uniQure N.V. (QURE) Investors: April 13, 2026, Deadline in Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP
February 21, 2026
RADNOR, PA - February 21, 2026 (NEWMEDIAWIRE) - Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against uniQure N.V. (NASDAQ: QURE)...
Via
TheNewswire.com
Topics
Fraud
Lawsuit
ROSEN, NATIONAL TRIAL LAWYERS, Encourages uniQure N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action - QURE
February 20, 2026
From
The Rosen Law Firm PA
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
